Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
0 hedge funds and large institutions have $0 invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $279 → $0 (-$279)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
-$254 |
| 2 |
Barclays
London,
United Kingdom
|
-$25 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JAIC
1
Josh Arnold Investment Consultant
Edina,
Minnesota
| – | -$254 | -363,132 | Closed |
|
|
2
Barclays
London,
United Kingdom
| – | -$25 | -35,824 | Closed |
|
CANO.WS Hedge Fund Activity: Q1 2024 in Review
0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q1 2024, worth a combined $0 — down 100% from $279 a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CANO.WS and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Josh Arnold Investment Consultant, exiting entirely with an estimated $254 sold.
- 0 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q1 2024, down from 2 in Q4 2023.
- Funds reported $0 of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q1 2024, down 100% quarter-over-quarter.
- 0 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q1 2024 and 2 closed out, a net change of -2 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q1 2024 was Josh Arnold Investment Consultant, an estimated $254 sold.
Based on aggregated 13F filings for Q1 2024.